International trade · 04/02/2000

US Commission Schedules Final Phase of Antidumping Investigation into Chinese Aspirin Imports

The US Commission is scheduling a final phase of an antidumping investigation into Chinese imports of bulk acetylsalicylic acid (aspirin) to determine if US industries are harmed by these imports. The investigation will focus on imports from China of aspirin, a key ingredient in pain relief medications.